Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced today that Jesper Høiland has been appointed to its Board of Directors and will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE